9. Grilli M, Ribola M, Alberici A, Valerio A, Memo M and
Spano PF, Identification and characterization of a kB/Rel
binding site in the regulatory region of the amyloid precursor 26.
protein gene. J Biol Chem 270: 26774 –26777, 1995.
10. Guerrini L, Blasi F and Denis-Donini S, Synaptic activation
of NF-kB by glutamate in cerebellar granule neurons in vitro. 27.
Proc Natl Acad Sci USA 92: 9077–9081, 1995.
11. Kaltschmidt C, Kaltschmidt B and Baeuerle PA, Stimulation
of ionotropic glutamate receptors activates transcription fac- 28.
tor NF-kB in primary neurons. Proc Natl Acad Sci USA 92:
9618 –9622, 1995.
12. Meberg PJ, Kinney WR, Valcourt EG and Routtenberg A, 29.
Gene expression of the transcription factor NF-kB in hippocampus: Regulation by synaptic activity. Brain Res Mol
Brain Res 38: 179 –190, 1996. 30.
13. Suzuki T, Mitake S, Okumura-Noji K, Yang J-P, Fujii T and
Okamoto T, Presence of NF-kB-like and IkB-like immunoreactivities in postsynaptic densities. Neuroreport 8: 2931– 31.
2935, 1997.
14. Sparacio SM, Zhang Y, Vilcek J and Benveniste EN, Cytokine regulation of interleukin-6 gene expression in astrocytes
involves activation of an NF-kB-like nuclear protein. J Neu- 32.
roimmunol 39: 231–242, 1992.
15. Kaltschmidt C, Kaltschmidt B, Lannes-Vieira J, Kreutzberg
GW, Wekerle H, Baeuerle PA and Gehrmann J, Transcription factor NF-kB is activated in microglia during experimen- 33.
tal autoimmune encephalomyelitis. J Neuroimmunol 55: 99 –
106, 1994.
16. Carter BD, Kaltschmidt C, Kaltschmidt B, Offenha ̈user N,
Bo ̈ hm-Matthaei R, Baeuerle PA and Barde Y-A, Selective
activation of NF-kB by nerve growth factor through the 34.
neurotrophin receptor p75. Science 272: 542–545, 1996.
17. Hou YN, Vlaskovska M, Cebers G, Kasakov L, Liljiequist S
and Terenius L, A μ-receptor opioid agonist induces AP-1
and NF-kB transcription factor activity in primary cultures of
rat cortical neurons. Neurosci Lett 212: 159 –162, 1996. 35.
18. Wood JN, Regulation of NF-kB activity in rat dorsal root
ganglia and PC12 cells by tumour necrosis factor and nerve
growth factor. Neurosci Lett 192: 41– 44, 1995.
19. Grilli M, Goffi F, Memo M and Spano PF, Interleukin-1β and 36.
glutamate activate the NF-kB/Rel binding site from the
regulatory region of the amyloid precursor protein gene in
primary neuronal cultures. J Biol Chem 271: 15002–15007,
1996.
20. Grilli M, Pizzi M, Memo M and Spano PF, Neuroprotection
by salicylate through blockade of NF-kB activation. Science
274: 1383–1385, 1996.
21. Yan SD, Yan SF, Chen X, Fu J, Chen M, Kuppusamy P, Smith 37.
MA, Perry G, Godman GC, Nawroth P, Zweier JL and Stern
D, Non-enzymatically glycated tau in Alzheimer's disease
induces neuronal oxidant stress resulting in cytokine gene 38.
expression and release of amyloid β-peptide. Nat Med 1:
693– 699, 1995.
22. Yan SD, Chen X, Fu J, Chen M, Zhu H, Roher A, Slattery T,
Zhao L, Nagashima M, Morser J, Migheli A, Nawroth P, 39.
Stern D and Schmidt AM, RAGE and amyloid-β peptide
neurotoxicity in Alzheimer's disease. Nature 382: 685– 691,
1996.
23. Kaltschmidt B, Uherek M, Volk B, Baeuerle PA and 40.
Kaltschmidt C, Transcription factor NF-kB is activated in
primary neurons by amyloid β peptides and in neurons
surrounding early plaques from patients with Alzheimer disease. Proc Natl Acad Sci USA 94: 2642–2647, 1997. 41.
Wu H and Lozano G, NF-kB activation of p53. A potential
mechanism for suppressing cell growth in response to stress.
J Biol Chem 269: 20067–20074, 1994.
Uberti D, Belloni M, Grilli M, Spano PF and Memo M,
Induction of tumour-suppressor phosphoprotein p53 in the
